The area under the curve (AUC) generated by receiver operating characteristic (ROC) curve analysis indicated the diagnostic efficacy of both SST and IGFBP7 in MS patients, as shown in Table 2. This evidence concerns the gene IGFBP7 and myeloid sarcoma.